The result of this study indicating that the BMC of heterozygous mutants was reduced by rapamycin, which is involved in mTOR signaling may provide some clue to elucidate the mechanisms of interosseous membrane calcification and hyperplastic callus formation in OI type V. The gene discussed is MTOR; the disease is osteogenesis imperfecta type 5.